Status:

UNKNOWN

Addition of Dydrogesterone to the Luteal Phase Support After Fresh Embryo Transfer

Lead Sponsor:

Laniado Hospital

Conditions:

Infertility

IVF

Eligibility:

FEMALE

18-45 years

Phase:

NA

Brief Summary

Randomized controlled study, open label to compare effectiveness of addition of dydrogesterone 20mg to the standard luteal phase support treatment after fresh embryos transfer.

Detailed Description

In the context of IVF treatment, it's a standard of care to use progesterone for endometrial synchronization and for luteal phase support after embryos transfer and until week 9-12 of pregnancy. In I...

Eligibility Criteria

Inclusion

  • Patients with a documented history of infertility who underwent IVF with or without ICSI, going through embryos transfer (having in the past up to 2 previous embryos transfer) and who gave written informed consent.
  • Body mass index ≥18 to ≤35 kg/m2
  • LH, prolactin (PRL), testosterone and thyroid-stimulating hormone (TSH) within normal clinical limits or not considered clinically significant within 1 year prior to or at screening
  • Normal transvaginal ultrasound at screening (or within 14 days prior to screening)
  • Planning a transfer of 1 or 2 fresh embryos.

Exclusion

  • Previous participation in this trial
  • Subjects with \>2 unsuccessful IVF attempts
  • Evidence of head, ear, eye, nose, throat, cardiovascular, respiratory, urogenital, gastrointestinal/hepatic, hematologic/immunologic, dermatologic/connective tissue, musculoskeletal, metabolic/nutritional, endocrine or neurologic/psychiatric disorders;
  • Recent major surgery (within 3 months);
  • Current or recent substance abuse, including that of alcohol and tobacco;
  • History of chemotherapy;
  • History of recurrent pregnancy loss (≥3 previous miscarriages)

Key Trial Info

Start Date :

April 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 31 2023

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT04408144

Start Date

April 1 2022

End Date

May 31 2023

Last Update

October 4 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Laniado Hospital

Netanya, Israel